Nuzenio

Preliminary Contested Proxy

Preliminary Contested Proxy entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 8 latest news signals 1 publisher sources 100/100 entity strength

Latest news

[PREC14A] Empery Digital Inc. Preliminary Contested Proxy Statement - Stock TitanStock Titan · Wed, 05 Aug 2026 21:31:34 GMTAngel Oak fund sets $0.115 August payout, payable Aug. 31 - Stock TitanStock Titan · Mon, 03 Aug 2026 20:18:47 GMTAnavex Life Sciences Announces Plans to Refresh Board to Continue Overseeing Critical Progress and Stockholder Value Creation - Stock TitanStock Titan · Mon, 03 Aug 2026 12:00:00 GMT[PREC14A] ANAVEX LIFE SCIENCES CORP. Preliminary Contested Proxy Statement - Stock TitanStock Titan · Fri, 31 Jul 2026 22:01:13 GMTQuince Therapeutics (QNCX) seeks approval for Orphai merger dilution and $115M PIPE - Stock TitanStock Titan · Fri, 31 Jul 2026 20:49:23 GMTVanguard Capital Management (NASDAQ: AVXL) discloses 5.03% beneficial stake in Anavex - Stock TitanStock Titan · Fri, 31 Jul 2026 13:55:28 GMTAnavex expects $127M cash to fund operations into 2028 - Stock TitanStock Titan · Thu, 30 Jul 2026 07:00:00 GMTSideChannel (SDCH) seeks big reduction in authorized stock and tax burden - Stock TitanStock Titan · Tue, 28 Jul 2026 07:00:00 GMT

Timeline

Wed, 05 Aug 2026 21:31:34 GMT[PREC14A] Empery Digital Inc. Preliminary Contested Proxy Statement - Stock Titan
Mon, 03 Aug 2026 20:18:47 GMTAngel Oak fund sets $0.115 August payout, payable Aug. 31 - Stock Titan
Mon, 03 Aug 2026 12:00:00 GMTAnavex Life Sciences Announces Plans to Refresh Board to Continue Overseeing Critical Progress and Stockholder Value Creation - Stock Titan
Fri, 31 Jul 2026 22:01:13 GMT[PREC14A] ANAVEX LIFE SCIENCES CORP. Preliminary Contested Proxy Statement - Stock Titan
Fri, 31 Jul 2026 20:49:23 GMTQuince Therapeutics (QNCX) seeks approval for Orphai merger dilution and $115M PIPE - Stock Titan
Fri, 31 Jul 2026 13:55:28 GMTVanguard Capital Management (NASDAQ: AVXL) discloses 5.03% beneficial stake in Anavex - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Preliminary Contested Proxy.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.